Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Utrecht
Clinical trial register · Netherlands

Clinical Trials in Utrecht, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3174 matching records held by the registry are in this view. Synced 16 Nov 2026, 03:18 UTC
3174
Studies in scope
all four open statuses
1791
Recruiting now
open to new participants
602
Lead sponsors
across recruiting studies
Top sites
Amsterdam 13 Rotterdam 8 Nijmegen 7 Utrecht 7 Leiden 7

Trials with a site in Utrecht

7 of 3174 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Active, closed
Genmab
Phase 3
191
Amsterdam, Harderwijk, Heerlen, Leiden, Nijmegen, Rotterdam, Utrecht, Zwolle
2024-11-25
Active, closed
Genmab
Phase 3
699
Amsterdam, Nijmegen, Utrecht
2024-09-25
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
Genmab
Phase 1/2
194
Maastricht, Dordrecht, Utrecht, Amsterdam, Groningen
2020-11-25
Active, closed
Genmab
Phase 1/2
543
Amsterdam, Groningen, Leiden, Maastricht, Rotterdam, Utrecht
2020-11-03
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
Genmab
Phase 1/2
666
Amsterdam, Maastricht, Rotterdam, Utrecht
2018-06-26
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
Genmab
Phase 1/2
560
Amsterdam, Nijmegen, Utrecht
2018-05-02
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/utrecht

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,174 studies in total at the last sync on 16 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Utrecht that also match the filters currently applied.

How many clinical trials are recruiting in Utrecht?

1 of the 7 studies on this page are recruiting new participants as of the 16 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Utrecht), 7 studies
PhaseStudiesRecruitingShare
Phase 1/24157.1%
Phase 33042.9%

Most active sponsors

Lead sponsors with the most studies (Utrecht)
Lead sponsorStudiesRecruiting
Genmab71
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.